Patents by Inventor Akshay NADKARNI

Akshay NADKARNI has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
    Publication number: 20220323352
    Abstract: A process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions may be used in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
    Type: Application
    Filed: June 27, 2022
    Publication date: October 13, 2022
    Inventors: Jean-Michel BUKOWSKI, Akshay NADKARNI, José L. BOYER, Brigitte DUQUESROIX-CHAKROUN, Tomas NAVRATIL
  • Process for the preparation of sterile ophthalmic aqueous fluticasone propionate form a nanocrystals suspensions
    Patent number: 11406596
    Abstract: A process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions may be used in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
    Type: Grant
    Filed: July 21, 2020
    Date of Patent: August 9, 2022
    Assignee: NICOX OPHTHALMICS, INC.
    Inventors: Jean-Michel Bukowski, Akshay Nadkarni, José L. Boyer, Brigitte Duquesroix-Chakroun, Tomas Navratil
  • PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
    Publication number: 20220241296
    Abstract: The present invention relates to an improved process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions are useful in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
    Type: Application
    Filed: July 21, 2020
    Publication date: August 4, 2022
    Inventors: Jean-Michel BUKOWSKI, Akshay NADKARNI, José L. BOYER, Brigitte DUQUESROIX-CHAKROUN, Tomas NAVRATIL
  • PROCESS FOR THE PREPARATION OF STERILE OPHTHALMIC AQUEOUS FLUTICASONE PROPIONATE FORM A NANOCRYSTALS SUSPENSIONS
    Publication number: 20210023001
    Abstract: A process of manufacturing sterile topical ophthalmic aqueous nanosuspensions of nanocrystals of fluticasone propionate Form A. The sterile topical ophthalmic nanosuspensions may be used in the treatment of eye inflammation conditions such as blepharitis, posterior blepharitis, Meibomian gland dysfunction and dry eye through topical administration of said nanosuspensions to eyelids, eyelashes and eyelid margin.
    Type: Application
    Filed: July 21, 2020
    Publication date: January 28, 2021
    Inventors: Jean-Michel BUKOWSKI, Akshay NADKARNI, José L. BOYER, Brigitte DUQUESROIX-CHAKROUN, Tomas NAVRATIL